Evidence map›Paper›PMID 25312506›Full record

ArticleExperimental animals2015

Preventive effect of safranal against oxidative damage in aged male rat brain.

Saeed Samarghandian, Mohsen Azimi-Nezhad, Fariborz Samini

Abstract read
In one paragraph

Article in Experimental animals, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Frontiers in medicine · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Pharmacological effects of Safranal: An updated review.Iranian journal of basic medical sciences · 2023
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Role of Herbal Medicines in the Management of Brain Injury.Advances in experimental medicine and biology · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Saeed SamarghandianDepartment of Basic Medical Sciences, Neyshabur University of Medical Sciences, Neyshabur, Iran.
Mohsen Azimi-Nezhad
Fariborz Samini

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An imbalance between production of reactive oxygen species (ROS) and its elimination by antioxidant defense system in the body has been implicated for causes of aging and neurodegenerative diseases. This study was design to assess the changes in activities of antioxidant enzymes (superoxide dismutase (SOD), glutathione-S-transferase (GST), catalase), lipid peroxidation and reduced glutathione (GSH) levels in the brain of 2, 10 and 20 month old rats, and to determine the effect of safranal on the status of selected oxidative stress indices in the 10 and 20 month old rats. The aged rats (10 and 20 months) were given intraperitoneal injections of safranal (0.5 mg/kg day) daily for one month. The results of this study demonstrated that aging caused significant increase in the level of lipid peroxidation as well decrease in the GSH level and activities of SOD and GST in the brain of aging rats. The results of this study showed that safranal ameliorated the increased lipid peroxidation level as well as decreased GSH content of the brain of 10 and 20 month old rats. In addition, safranal treatment to the 20 month old rats, which restored the SOD and GST activities. In conclusion, safranal can be effective to protect susceptible aged brain from oxidative damage by increasing antioxidant defenses.

Indexed as

AgingAnimalsAntioxidantsBrainCatalaseCyclohexenesGlutathioneGlutathione TransferaseInjections, IntraperitonealLipid PeroxidationLipid PeroxidesMaleNeurodegenerative DiseasesRats, WistarReactive Oxygen SpeciesSuperoxide DismutaseAntioxidantsCatalaseCyclohexenesGlutathioneGlutathione TransferaseLipid PeroxidesReactive Oxygen SpeciessafranalSuperoxide DismutaseTerpenes

Identifiers

PMID25312506
PMCPMC4329517

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.